Overview
Imidazole derivative anesthetic and hypnotic with little effect on blood gases, ventilation, or the cardiovascular system. It has been proposed as an induction anesthetic.
Indication
Used in the induction of general anesthesia.
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2025/07/22 | Not Applicable | Not yet recruiting | |||
2025/06/10 | Early Phase 1 | Not yet recruiting | Second Hospital of Shanxi Medical University | ||
2025/03/05 | Phase 3 | Not yet recruiting | Ahon Pharmaceutical Co., Ltd. | ||
2024/11/12 | Phase 2 | Completed | Ahon Pharmaceutical Co., Ltd. | ||
2024/10/29 | Phase 4 | Completed | Yeongseok Yun | ||
2024/01/12 | Phase 3 | Recruiting | Ahon Pharmaceutical Co., Ltd. | ||
2023/12/22 | N/A | ENROLLING_BY_INVITATION | |||
2023/10/05 | Phase 4 | Recruiting | |||
2023/04/12 | Not Applicable | Completed | Ailin Luo | ||
2023/03/01 | Not Applicable | Completed | Xijing Hospital |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| Eugia US LLC | 55150-221 | INTRAVENOUS | 20 mg in 10 mL | 7/5/2023 | |
| Armas Pharmaceuticals Inc. | 72485-509 | INTRAVENOUS | 2 mg in 1 mL | 1/22/2024 | |
| Fresenius Kabi USA, LLC | 65219-447 | INTRAVENOUS | 2 mg in 1 mL | 7/14/2021 | |
| Zydus Pharmaceuticals USA Inc. | 68382-545 | INTRAVENOUS | 2 mg in 1 mL | 11/14/2022 | |
| HF Acquisition Co LLC, DBA HealthFirst | 51662-1459 | INTRAVENOUS | 2 mg in 1 mL | 10/10/2023 | |
| HF Acquisition Co LLC, DBA HealthFirst | 51662-1455 | INTRAVENOUS | 2 mg in 1 mL | 2/23/2020 | |
| Caplin Steriles Limited | 65145-128 | INTRAVENOUS | 2 mg in 1 mL | 12/30/2020 | |
| Hikma Pharmaceuticals USA Inc. | 0143-9507 | INTRAVENOUS | 2 mg in 1 mL | 12/6/2023 | |
| Hikma Pharmaceuticals USA Inc. | 0143-9506 | INTRAVENOUS | 2 mg in 1 mL | 12/6/2023 | |
| Eugia US LLC | 55150-222 | INTRAVENOUS | 40 mg in 20 mL | 7/5/2023 |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| ETOMIDATE-LIPURO INJECTION 20 mg/10 ml | SIN08849P | INJECTION | 20 mg/10 ml | 8/14/1996 |
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| ETOMIDATE-LIPURO INJ 20MG/10ML | N/A | N/A | N/A | 1/10/1996 |
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
|---|---|---|---|---|---|
| TOMVI | Sterimax Inc | 02498650 | Solution - Intravenous | 2 MG / ML | 9/14/2020 |
| ETOMIDATE INJECTION USP | marcan pharmaceuticals inc | 02525453 | Solution - Intravenous | 2 MG / ML | 5/20/2022 |
| ETOMIDATE INJECTION, USP | fresenius kabi canada ltd | 02537508 | Solution - Intravenous | 2 MG / ML | 7/3/2024 |
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
|---|---|---|---|---|---|
| HYPNOMIDATE 2 mg/ml SOLUCION INYECTABLE | 57562 | SOLUCIÓN INYECTABLE | Uso Hospitalario | Commercialized | |
| ETOMIDATO -LIPURO 2 mg/ml EMULSION INYECTABLE | 64095 | EMULSIÓN INYECTABLE | Uso Hospitalario | Commercialized |
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Philippines FDA approvals found for this drug. | |||||
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Saudi SFDA approvals found for this drug. | |||||
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Malaysia NPRA approvals found for this drug. | |||||
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
|---|---|---|---|---|---|
| No UK EMC drug information found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.